/People

Robert Tansley

Investor

Partner at Cambridge Innovation Capital

Cambridge, United Kingdom

Writes $600K – $6M checks · typically $3.3M

Find your path to Robert

Sign up to see every warm intro you have to Robert

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Robert. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Robert Tansley is a trained surgeon-turned-investor who leverages clinical experience, backing major medtechs like CMR Surgical, serving as CMO and translating Cambridge academic research into scalable life sciences companies.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechDeep TechHardwareHealthtechSemiconductors

Investments

Board seats

Inivata

Sources: SEC Form D filings · the firm's website · curated public sources.

Colleagues at Cambridge Innovation Capital

Network1

Investors connected to Robert in public investor directories — a warm-intro map.

Frequently asked questions

Who is Robert Tansley?
Robert Tansley is a trained surgeon-turned-investor who leverages clinical experience, backing major medtechs like CMR Surgical, serving as CMO and translating Cambridge academic research into scalable life sciences companies.
Where does Robert Tansley work?
Robert Tansley is Partner at Cambridge Innovation Capital.
What does Robert Tansley invest in?
Robert Tansley invests in AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Semiconductors.
What check size does Robert Tansley write?
Robert Tansley typically writes checks of $600K – $6M.
What boards does Robert Tansley sit on?
Robert Tansley holds tracked board seats at Inivata.
What companies has Robert Tansley invested in?
Investments tracked here include Abcodia, Carrick Therapeutics, Cmr Surgical, Congenica, Gyroscopetx, Inivata, Microbiotica, Morphogen-IX, PetMedix, Pretzel Therapeutics, Sortera Bio, Sortera.bio, and 3 more.

About this profile. Compiled from public sources — Cambridge Innovation Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights